116 related articles for article (PubMed ID: 35443207)
1. Proof‑of‑concept study to quantify changes in intestinal loads of KPC-producing Klebsiella pneumoniae in colonised patients following selective digestive decontamination with oral gentamicin.
Pérez-Nadales E; Natera AM; Recio-Rufíán M; Guzmán-Puche J; Cano Á; Frutos-Adame A; Castón JJ; Elías-López C; Romero-Saldaña M; López-Cerero L; Martínez-Martínez L; Torre-Cisneros J
J Glob Antimicrob Resist; 2022 Sep; 30():16-22. PubMed ID: 35443207
[TBL] [Abstract][Full Text] [Related]
2. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience.
Lübbert C; Faucheux S; Becker-Rux D; Laudi S; Dürrbeck A; Busch T; Gastmeier P; Eckmanns T; Rodloff AC; Kaisers UX
Int J Antimicrob Agents; 2013 Dec; 42(6):565-70. PubMed ID: 24100228
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of the Relative Load of KPC-Producing Klebsiella pneumoniae within the Intestinal Microbiota in a Prospective Cohort of Colonized Patients.
Pérez-Nadales E; M Natera A; Recio-Rufián M; Guzmán-Puche J; Marín-Sanz JA; Martín-Pérez C; Cano Á; Castón JJ; Elías-López C; Machuca I; Gutiérrez-Gutiérrez B; Martínez-Martínez L; Torre-Cisneros J
Microbiol Spectr; 2022 Aug; 10(4):e0272821. PubMed ID: 35766500
[TBL] [Abstract][Full Text] [Related]
4. Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: relevance of concomitant systemic antibiotic therapy.
Tascini C; Sbrana F; Flammini S; Tagliaferri E; Arena F; Leonildi A; Ciullo I; Amadori F; Di Paolo A; Ripoli A; Lewis R; Rossolini GM; Menichetti F;
Antimicrob Agents Chemother; 2014; 58(4):1972-6. PubMed ID: 24419337
[TBL] [Abstract][Full Text] [Related]
5. Increased Relative Abundance of Klebsiella pneumoniae Carbapenemase-producing Klebsiella pneumoniae Within the Gut Microbiota Is Associated With Risk of Bloodstream Infection in Long-term Acute Care Hospital Patients.
Shimasaki T; Seekatz A; Bassis C; Rhee Y; Yelin RD; Fogg L; Dangana T; Cisneros EC; Weinstein RA; Okamoto K; Lolans K; Schoeny M; Lin MY; Moore NM; Young VB; Hayden MK;
Clin Infect Dis; 2019 May; 68(12):2053-2059. PubMed ID: 30239622
[TBL] [Abstract][Full Text] [Related]
6. Oral gentamicin therapy for Carbapenem-resistant Klebsiella pneumoniae gut colonization in hematologic patients: a single center experience.
Lambelet P; Tascini C; Fortunato S; Stefanelli A; Simonetti F; Vettori C; Leonildi A; Menichetti F
New Microbiol; 2017 Jul; 40(3):161-164. PubMed ID: 28513809
[TBL] [Abstract][Full Text] [Related]
7. Randomised, double-blind, placebo-controlled, phase 2, superiority trial to demonstrate the effectiveness of faecal microbiota transplantation for selective intestinal decolonisation of patients colonised by carbapenemase-producing
Pérez-Nadales E; Cano Á; Recio M; Artacho MJ; Guzmán-Puche J; Doblas A; Vidal E; Natera C; Martínez-Martínez L; Torre-Cisneros J; Castón JJ
BMJ Open; 2022 Apr; 12(4):e058124. PubMed ID: 35387830
[TBL] [Abstract][Full Text] [Related]
8. Association between rectal colonisation by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae and mortality: a prospective, observational study.
Cano Á; Gutiérrez-Gutiérrez B; Machuca I; Torre-Giménez J; Frutos-Adame A; García-Gutiérrez M; Gallo-Marín M; Gracia-Ahufinger I; Artacho MJ; Natera AM; Pérez-Nadales E; Castón JJ; Mameli S; Gómez-Delgado F; de la Fuente C; Salcedo I; Rodríguez-Baño J; Martínez-Martínez L; Torre-Cisneros J
J Glob Antimicrob Resist; 2022 Jun; 29():476-482. PubMed ID: 34788693
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage.
Saidel-Odes L; Polachek H; Peled N; Riesenberg K; Schlaeffer F; Trabelsi Y; Eskira S; Yousef B; Smolykov R; Codish S; Borer A
Infect Control Hosp Epidemiol; 2012 Jan; 33(1):14-9. PubMed ID: 22173517
[TBL] [Abstract][Full Text] [Related]
10. Changing epidemiology of KPC-producing Klebsiella pneumoniae in Argentina: Emergence of hypermucoviscous ST25 and high-risk clone ST307.
Cejas D; Elena A; Guevara Nuñez D; Sevillano Platero P; De Paulis A; Magariños F; Alfonso C; Berger MA; Fernández-Canigia L; Gutkind G; Radice M
J Glob Antimicrob Resist; 2019 Sep; 18():238-242. PubMed ID: 31202977
[TBL] [Abstract][Full Text] [Related]
11. Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing
Huang Y; Sokolowski K; Rana A; Singh N; Wang J; Chen K; Lang Y; Zhou J; Kadiyala N; Krapp F; Ozer EA; Hauser AR; Li J; Bulitta JB; Bulman ZP
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0069221. PubMed ID: 34152820
[TBL] [Abstract][Full Text] [Related]
12. Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments.
Gaibani P; Bovo F; Bussini L; Lazzarotto T; Amadesi S; Bartoletti M; Viale P; Ambretti S
J Antimicrob Chemother; 2022 May; 77(6):1570-1577. PubMed ID: 35373297
[TBL] [Abstract][Full Text] [Related]
13. In vivo selection of KPC-94 and KPC-95 in Klebsiella pneumoniae isolates from patients treated with ceftazidime/avibactam.
Guzmán-Puche J; Pérez-Nadales E; Pérez-Vázquez M; Causse M; Gracia-Ahufinger I; Mendez-Natera A; Allalou-Ruiz Y; Elías C; Oteo-Iglesias J; Torre-Cisneros J; Martínez-Martínez L
Int J Antimicrob Agents; 2022 Feb; 59(2):106524. PubMed ID: 35038557
[TBL] [Abstract][Full Text] [Related]
14. A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates.
Spyropoulou A; Papadimitriou-Olivgeris M; Bartzavali C; Vamvakopoulou S; Marangos M; Spiliopoulou I; Anastassiou ED; Christofidou M
J Med Microbiol; 2016 Mar; 65(3):240-246. PubMed ID: 26698320
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.
Papadimitriou-Olivgeris M; Marangos M; Christofidou M; Fligou F; Bartzavali C; Panteli ES; Vamvakopoulou S; Filos KS; Anastassiou ED
Scand J Infect Dis; 2014 Sep; 46(9):642-8. PubMed ID: 25017796
[TBL] [Abstract][Full Text] [Related]
16. Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany.
Lübbert C; Lippmann N; Busch T; Kaisers UX; Ducomble T; Eckmanns T; Rodloff AC
Am J Infect Control; 2014 Apr; 42(4):376-80. PubMed ID: 24679563
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of urinary tract infection caused by KPC-producing Klebsiella pneumoniae: The impact of inappropriate empirical treatment.
Rodriguez-Gómez J; Pérez-Nadales E; Gutiérrez-Gutiérrez B; Machuca I; Martinez-Martinez L; Rivera F; Cano A; Castón JJ; Robles JC; de la Fuente C; Rodríguez-López F; Rodriguez-Baño J; Torre-Cisneros J;
J Infect; 2019 Sep; 79(3):245-252. PubMed ID: 31276705
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage.
Feldman N; Adler A; Molshatzki N; Navon-Venezia S; Khabra E; Cohen D; Carmeli Y
Clin Microbiol Infect; 2013 Apr; 19(4):E190-6. PubMed ID: 23331385
[TBL] [Abstract][Full Text] [Related]
19. In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment.
Gaibani P; Campoli C; Lewis RE; Volpe SL; Scaltriti E; Giannella M; Pongolini S; Berlingeri A; Cristini F; Bartoletti M; Tedeschi S; Ambretti S
J Antimicrob Chemother; 2018 Jun; 73(6):1525-1529. PubMed ID: 29566151
[TBL] [Abstract][Full Text] [Related]
20. Carbapenem antibiotic stress increases bla
Chen H; Li N; Wang F; Wang L; Liang W
J Clin Lab Anal; 2022 Jul; 36(7):e24519. PubMed ID: 35718993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
